-
Vaccine Approved
US FDA approved MenQuadfi, the first quadrivalent meningococcal vaccine aged two years and above. The vaccine uses tetanus toxoid as a protein carrier and…
Continue reading
US FDA approved MenQuadfi, the first quadrivalent meningococcal vaccine aged two years and above. The vaccine uses tetanus toxoid as a protein carrier and…